Annual FCF
-$37.98 M
-$31.75 M-509.03%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual free cash flow is -$37.98 million, with the most recent change of -$31.75 million (-509.03%) on December 1, 2023.
- During the last 3 years, CATX annual FCF has fallen by -$34.77 million (-1080.39%).
- CATX annual FCF is now -12101.58% below its all-time high of $316.50 thousand, reached on September 1, 1999.
Performance
CATX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$26.35 M
-$16.43 M-165.68%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly free cash flow is -$26.35 million, with the most recent change of -$16.43 million (-165.68%) on September 1, 2024.
- Over the past year, CATX quarterly FCF has dropped by -$16.01 million (-154.88%).
- CATX quarterly FCF is now -651.65% below its all-time high of $4.78 million, reached on March 1, 2024.
Performance
CATX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$40.59 M
-$16.01 M-65.15%
September 1, 2024
Summary
- As of February 7, 2025, CATX TTM free cash flow is -$40.59 million, with the most recent change of -$16.01 million (-65.15%) on September 1, 2024.
- Over the past year, CATX TTM FCF has dropped by -$11.70 million (-40.49%).
- CATX TTM FCF is now -12919.01% below its all-time high of $316.60 thousand, reached on September 1, 1999.
Performance
CATX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CATX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -509.0% | -154.9% | -40.5% |
| 3 y3 years | -1080.4% | -165.5% | -174.7% |
| 5 y5 years | -591.5% | -165.5% | -174.7% |
CATX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1080.4% | at low | -651.6% | at low | -640.7% | at low |
| 5 y | 5-year | -1080.4% | at low | -651.6% | at low | -1320.0% | at low |
| alltime | all time | <-9999.0% | +35.8% | -651.6% | at low | <-9999.0% | at low |
Perspective Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$26.35 M(+165.7%) | -$40.59 M(+65.1%) |
| Jun 2024 | - | -$9.92 M(-307.6%) | -$24.57 M(+5.5%) |
| Mar 2024 | - | $4.78 M(-152.5%) | -$23.29 M(-38.7%) |
| Dec 2023 | -$37.98 M(+509.0%) | -$9.10 M(-12.0%) | -$37.98 M(+31.5%) |
| Sep 2023 | - | -$10.34 M(+19.8%) | -$28.89 M(+41.6%) |
| Jun 2023 | - | -$8.63 M(-13.1%) | -$20.40 M(+38.1%) |
| Mar 2023 | - | -$9.92 M(+435.6%) | -$14.77 M(+92.1%) |
| Dec 2022 | -$6.24 M(-21.8%) | - | - |
| Sep 2022 | - | -$1.85 M(-38.2%) | -$7.69 M(-3.6%) |
| Jun 2022 | - | -$3.00 M(+106.9%) | -$7.98 M(+28.4%) |
| Jun 2022 | -$7.98 M(+147.9%) | - | - |
| Mar 2022 | - | -$1.45 M(+3.9%) | -$6.21 M(+13.4%) |
| Dec 2021 | - | -$1.39 M(-34.8%) | -$5.48 M(+11.7%) |
| Sep 2021 | - | -$2.14 M(+73.4%) | -$4.91 M(+52.4%) |
| Jun 2021 | -$3.22 M(-17.8%) | - | - |
| Jun 2021 | - | -$1.23 M(+72.7%) | -$3.22 M(+12.6%) |
| Mar 2021 | - | -$714.00 K(-12.9%) | -$2.86 M(-6.3%) |
| Dec 2020 | - | -$820.00 K(+81.8%) | -$3.05 M(-15.6%) |
| Sep 2020 | - | -$451.00 K(-48.3%) | -$3.61 M(-7.7%) |
| Jun 2020 | -$3.91 M(-28.7%) | -$873.00 K(-3.6%) | -$3.91 M(-4.9%) |
| Mar 2020 | - | -$906.00 K(-34.5%) | -$4.12 M(-12.0%) |
| Dec 2019 | - | -$1.38 M(+84.3%) | -$4.68 M(+3.5%) |
| Sep 2019 | - | -$751.00 K(-30.2%) | -$4.52 M(-17.7%) |
| Jun 2019 | -$5.49 M(-9.2%) | -$1.08 M(-26.6%) | -$5.49 M(-8.0%) |
| Mar 2019 | - | -$1.47 M(+19.7%) | -$5.97 M(+5.4%) |
| Dec 2018 | - | -$1.23 M(-29.0%) | -$5.67 M(-6.5%) |
| Sep 2018 | - | -$1.73 M(+11.1%) | -$6.06 M(+0.2%) |
| Jun 2018 | -$6.05 M(-3.4%) | -$1.55 M(+33.9%) | -$6.05 M(+1.4%) |
| Mar 2018 | - | -$1.16 M(-28.3%) | -$5.96 M(-6.0%) |
| Dec 2017 | - | -$1.62 M(-5.6%) | -$6.34 M(-2.1%) |
| Sep 2017 | - | -$1.72 M(+16.7%) | -$6.48 M(+3.4%) |
| Jun 2017 | -$6.26 M(+43.5%) | -$1.47 M(-4.5%) | -$6.26 M(+0.7%) |
| Mar 2017 | - | -$1.54 M(-12.2%) | -$6.22 M(+9.9%) |
| Dec 2016 | - | -$1.75 M(+16.9%) | -$5.66 M(+19.2%) |
| Sep 2016 | - | -$1.50 M(+5.1%) | -$4.75 M(+8.9%) |
| Jun 2016 | -$4.36 M(+19.4%) | -$1.43 M(+45.5%) | -$4.36 M(+21.0%) |
| Mar 2016 | - | -$981.00 K(+16.5%) | -$3.61 M(-5.1%) |
| Dec 2015 | - | -$842.00 K(-24.3%) | -$3.80 M(+5.2%) |
| Sep 2015 | - | -$1.11 M(+66.0%) | -$3.62 M(-1.1%) |
| Jun 2015 | -$3.65 M(+11.9%) | -$670.60 K(-43.0%) | -$3.65 M(-8.4%) |
| Mar 2015 | - | -$1.18 M(+79.4%) | -$3.99 M(+20.2%) |
| Dec 2014 | - | -$655.60 K(-43.1%) | -$3.32 M(-5.7%) |
| Sep 2014 | - | -$1.15 M(+14.8%) | -$3.52 M(+7.9%) |
| Jun 2014 | -$3.27 M(+6.4%) | -$1.00 M(+98.2%) | -$3.26 M(+7.2%) |
| Mar 2014 | - | -$506.70 K(-40.9%) | -$3.05 M(-7.6%) |
| Dec 2013 | - | -$857.30 K(-4.4%) | -$3.30 M(+9.2%) |
| Sep 2013 | - | -$896.60 K(+14.1%) | -$3.02 M(-1.6%) |
| Jun 2013 | -$3.07 M(+20.7%) | -$786.10 K(+3.9%) | -$3.07 M(+4.6%) |
| Mar 2013 | - | -$756.50 K(+30.2%) | -$2.93 M(-3.1%) |
| Dec 2012 | - | -$580.90 K(-38.6%) | -$3.03 M(+3.3%) |
| Sep 2012 | - | -$945.50 K(+45.5%) | -$2.93 M(+15.2%) |
| Jun 2012 | -$2.54 M(-1.3%) | -$650.00 K(-23.7%) | -$2.54 M(-0.5%) |
| Mar 2012 | - | -$851.50 K(+76.0%) | -$2.56 M(+11.2%) |
| Dec 2011 | - | -$483.80 K(-13.3%) | -$2.30 M(-7.8%) |
| Sep 2011 | - | -$557.90 K(-15.8%) | -$2.49 M(-3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | -$2.58 M(-5.3%) | -$662.40 K(+11.7%) | -$2.58 M(+0.2%) |
| Mar 2011 | - | -$593.10 K(-12.6%) | -$2.57 M(-2.9%) |
| Dec 2010 | - | -$678.50 K(+5.7%) | -$2.65 M(-6.7%) |
| Sep 2010 | - | -$642.20 K(-2.2%) | -$2.84 M(+4.4%) |
| Jun 2010 | -$2.72 M(-32.8%) | -$656.90 K(-2.0%) | -$2.72 M(-9.7%) |
| Mar 2010 | - | -$670.10 K(-22.9%) | -$3.01 M(-4.5%) |
| Dec 2009 | - | -$869.30 K(+66.0%) | -$3.15 M(-11.3%) |
| Sep 2009 | - | -$523.60 K(-44.8%) | -$3.55 M(-12.1%) |
| Jun 2009 | -$4.04 M(-63.6%) | -$947.70 K(+16.7%) | -$4.04 M(-4.5%) |
| Mar 2009 | - | -$811.90 K(-36.1%) | -$4.24 M(-21.7%) |
| Dec 2008 | - | -$1.27 M(+25.4%) | -$5.41 M(-25.4%) |
| Sep 2008 | - | -$1.01 M(-11.0%) | -$7.26 M(-34.7%) |
| Jun 2008 | -$11.11 M(+14.8%) | -$1.14 M(-42.7%) | -$11.11 M(-11.4%) |
| Mar 2008 | - | -$1.99 M(-36.3%) | -$12.54 M(-6.1%) |
| Dec 2007 | - | -$3.12 M(-35.9%) | -$13.36 M(+7.2%) |
| Sep 2007 | - | -$4.86 M(+89.3%) | -$12.47 M(+28.9%) |
| Jun 2007 | -$9.68 M(+23.4%) | -$2.57 M(-8.5%) | -$9.68 M(+9.3%) |
| Mar 2007 | - | -$2.81 M(+26.1%) | -$8.85 M(+10.7%) |
| Dec 2006 | - | -$2.23 M(+7.4%) | -$7.99 M(+2.7%) |
| Sep 2006 | - | -$2.07 M(+18.8%) | -$7.79 M(-0.7%) |
| Jun 2006 | -$7.84 M(-86.7%) | -$1.74 M(-10.5%) | -$7.84 M(+28.6%) |
| Mar 2006 | - | -$1.95 M(-3.5%) | -$6.10 M(+46.9%) |
| Dec 2005 | - | -$2.02 M(-5.1%) | -$4.15 M(+94.5%) |
| Sep 2005 | - | -$2.13 M(>+9900.0%) | -$2.13 M(>+9900.0%) |
| Jun 2005 | -$59.17 M(>+9900.0%) | - | - |
| Mar 2005 | - | -$2400.00(-33.3%) | -$11.40 K(+7.5%) |
| Dec 2004 | - | -$3600.00(-5.3%) | -$10.60 K(+7.1%) |
| Sep 2004 | -$9900.00(-47.9%) | -$3800.00(+137.5%) | -$9900.00(-24.4%) |
| Jun 2004 | - | -$1600.00(0.0%) | -$13.10 K(-1.5%) |
| Mar 2004 | - | -$1600.00(-44.8%) | -$13.30 K(-7.6%) |
| Dec 2003 | - | -$2900.00(-58.6%) | -$14.40 K(-24.6%) |
| Sep 2003 | -$19.00 K(+113.5%) | -$7000.00(+288.9%) | -$19.10 K(+45.8%) |
| Jun 2003 | - | -$1800.00(-33.3%) | -$13.10 K(+2.3%) |
| Mar 2003 | - | -$2700.00(-64.5%) | -$12.80 K(-14.7%) |
| Dec 2002 | - | -$7600.00(+660.0%) | -$15.00 K(+68.5%) |
| Sep 2002 | -$8900.00(-39.5%) | -$1000.00(-33.3%) | -$8900.00(+1.1%) |
| Jun 2002 | - | -$1500.00(-69.4%) | -$8800.00(-51.4%) |
| Mar 2002 | - | -$4900.00(+226.7%) | -$18.10 K(+27.5%) |
| Dec 2001 | - | -$1500.00(+66.7%) | -$14.20 K(-4.1%) |
| Sep 2001 | -$14.70 K(+98.6%) | -$900.00(-91.7%) | -$14.80 K(-30.2%) |
| Jun 2001 | - | -$10.80 K(+980.0%) | -$21.20 K(+103.8%) |
| Mar 2001 | - | -$1000.00(-52.4%) | -$10.40 K(+10.6%) |
| Dec 2000 | - | -$2100.00(-71.2%) | -$9400.00(+28.8%) |
| Sep 2000 | -$7400.00(-102.3%) | -$7300.00(<-9900.0%) | -$7300.00(-102.9%) |
| Jun 2000 | - | $0.00(0.0%) | $248.30 K(+0.3%) |
| Mar 2000 | - | $0.00(0.0%) | $247.60 K(-0.2%) |
| Dec 1999 | - | $0.00(-100.0%) | $248.10 K(-21.6%) |
| Sep 1999 | $316.50 K(+171.9%) | $248.30 K(<-9900.0%) | $316.60 K(+363.5%) |
| Jun 1999 | - | -$700.00(-240.0%) | $68.30 K(-1.0%) |
| Mar 1999 | - | $500.00(-99.3%) | $69.00 K(+0.7%) |
| Dec 1998 | - | $68.50 K | $68.50 K |
| Sep 1998 | $116.40 K(-417.2%) | - | - |
| Sep 1997 | -$36.70 K(-96.7%) | - | - |
| Sep 1996 | -$1.12 M(+105.7%) | - | - |
| Sep 1995 | -$546.50 K(+1.6%) | - | - |
| Sep 1994 | -$538.00 K | - | - |
FAQ
- What is Perspective Therapeutics annual free cash flow?
- What is the all time high annual FCF for Perspective Therapeutics?
- What is Perspective Therapeutics annual FCF year-on-year change?
- What is Perspective Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly FCF year-on-year change?
- What is Perspective Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Perspective Therapeutics?
- What is Perspective Therapeutics TTM FCF year-on-year change?
What is Perspective Therapeutics annual free cash flow?
The current annual FCF of CATX is -$37.98 M
What is the all time high annual FCF for Perspective Therapeutics?
Perspective Therapeutics all-time high annual free cash flow is $316.50 K
What is Perspective Therapeutics annual FCF year-on-year change?
Over the past year, CATX annual free cash flow has changed by -$31.75 M (-509.03%)
What is Perspective Therapeutics quarterly free cash flow?
The current quarterly FCF of CATX is -$26.35 M
What is the all time high quarterly FCF for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly free cash flow is $4.78 M
What is Perspective Therapeutics quarterly FCF year-on-year change?
Over the past year, CATX quarterly free cash flow has changed by -$16.01 M (-154.88%)
What is Perspective Therapeutics TTM free cash flow?
The current TTM FCF of CATX is -$40.59 M
What is the all time high TTM FCF for Perspective Therapeutics?
Perspective Therapeutics all-time high TTM free cash flow is $316.60 K
What is Perspective Therapeutics TTM FCF year-on-year change?
Over the past year, CATX TTM free cash flow has changed by -$11.70 M (-40.49%)